Priming a vascular-selective cytokine response permits CD8+ T-cell entry into tumors.
Kim DJ, Anandh S, Null JL, Przanowski P, Bhatnagar S, Kumar P, Shelton SE, Grundy EE, Chiappinelli KB, Kamm RD, Barbie DA, Dudley AC.
Kim DJ, et al. Among authors: dudley ac.
Nat Commun. 2023 Apr 14;14(1):2122. doi: 10.1038/s41467-023-37807-z.
Nat Commun. 2023.
PMID: 37055433
Free PMC article.